We are live on
!
Find out more
BCM
Bridgeway Capital Management Portfolio holdings
AUM
$4.97B
1-Year Est. Return
44.96%
This Fund
S&P 500
This Quarter
Est. Return
+6.61%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$4.18B
AUM Growth
+$413M
(+11%)
Cap. Flow
+$293M
Cap. Flow
% of AUM
7.01%
Top 10 Holdings %
Top 10 Hldgs %
6.7%
Holding
1,500
New
123
Increased
567
Reduced
324
Closed
123
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$20M |
| 2 |
NVIDIA
NVDA
|
+$19M |
| 3 |
Johnson & Johnson
JNJ
|
+$14.9M |
| 4 |
Coca-Cola
KO
|
+$14.6M |
| 5 |
Microsoft
MSFT
|
+$13.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TA
TravelCenters of America LLC
TA
|
+$21.5M |
| 2 |
PR
Permian Resources
PR
|
+$14.3M |
| 3 |
PBF Energy
PBF
|
+$12.6M |
| 4 |
Genworth Financial
GNW
|
+$11.6M |
| 5 |
Cigna
CI
|
+$11.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.63% |
| 2 | Consumer Discretionary | 12.15% |
| 3 | Technology | 12.08% |
| 4 | Industrials | 12% |
| 5 | Healthcare | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STRR
901
Star Equity Holdings
STRR
$42.4M
| $498K | 0.01% |
22,380
| – | – |
|
|
MKFG
902
DELISTED
Markforged Holding Corporation
MKFG
| $495K | 0.01% |
40,950
+5,950
| +17% | +$56.1K |
|
903
4D Molecular Therapeutics
FDMT
$552M
| $495K | 0.01% |
27,400
| – | – |
|
|
FSFG
904
DELISTED
First Savings Financial Group
FSFG
| $495K | 0.01% |
37,471
+806
| +2% | +$10.9K |
|
905
Caesarstone
CSTE
$76.1M
| $490K | 0.01% |
93,600
-13,500
| -13% | -$61.2K |
|
|
OPTN
906
DELISTED
OptiNose
OPTN
| $490K | 0.01% |
26,533
+3,706
| +16% | +$87.7K |
|
907
The RealReal
REAL
$1.54B
| $490K | 0.01% |
220,500
| – | – |
|
908
Graham Corp
GHM
$1.23B
| $489K | 0.01% |
36,795
-3,200
| -8% | -$40.3K |
|
909
ThredUp
TDUP
$401M
| $488K | 0.01% |
200,000
| – | – |
|
910
Goldgroup Mining Inc.
GORO
$160M
| $488K | 0.01% |
774,098
-964,950
| -55% | -$855K |
|
911
Gencor Industries
GENC
$212M
| $485K | 0.01% |
31,150
| – | – |
|
912
Zevra Therapeutics
ZVRA
$702M
| $485K | 0.01% |
95,143
| – | – |
|
913
Avita Medical
RCEL
$146M
| $485K | 0.01% |
28,518
| – | – |
|
914
Rigel Pharmaceuticals
RIGL
$733M
| $484K | 0.01% |
37,500
+11,500
| +44% | +$155K |
|
|
KZR
915
DELISTED
Kezar Life Sciences
KZR
| $479K | 0.01% |
+19,550
| New | +$509K |
|
916
Actinium Pharmaceuticals
ATNM
$24.7M
| $475K | 0.01% |
63,966
| – | – |
|
917
Blend Labs
BLND
$472M
| $474K | 0.01% |
+500,000
| New | +$443K |
|
918
LifeMD
LFMD
$164M
| $471K | 0.01% |
108,300
+15,500
| +17% | +$34.4K |
|
919
Kewaunee Scientific
KEQU
$109M
| $471K | 0.01% |
30,400
| – | – |
|
|
FLNT
920
Fluent
FLNT
$114M
| $467K | 0.01% |
124,302
+1,405
| +1% | +$5.91K |
|
921
Escalade
ESCA
$306M
| $466K | 0.01% |
34,908
+400
| +1% | +$5.44K |
|
922
Altimmune
ALT
$585M
| $465K | 0.01% |
+131,700
| New | +$591K |
|
923
Red Robin
RRGB
$156M
| $463K | 0.01% |
33,500
| – | – |
|
924
Cardlytics
CDLX
$20.4M
| $461K | 0.01% |
+7,300
| New | +$442K |
|
|
DBTX
925
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
| $459K | 0.01% |
119,100
| – | – |
|
Similar funds
SNT
MA
FFB
AM
SGM
PAMP
SMFG
SIA
Bridgeway Capital Management's Q2 2023 Portfolio in Review
As of Q2 2023, Bridgeway Capital Management held 1,500 positions worth $4.18B, up 11% from $3.77B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Bridgeway Capital Management deployed $293M of net new capital in Q2 2023, opening 123 new positions and adding to 567 existing holdings. Its largest new stake was Tronox: 919,025 shares worth $11.7M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Permian Resources, an estimated $14.3M trimmed.
- Bridgeway Capital Management's largest Q2 2023 buy was Tronox: 919,025 shares worth $11.7M.
- Bridgeway Capital Management added most to JPMorgan Chase in Q2 2023, an estimated $20M increase.
- Bridgeway Capital Management's biggest Q2 2023 reduction was Permian Resources, cutting an estimated $14.3M.
- Bridgeway Capital Management fully exited TravelCenters of America LLC in Q2 2023, selling an estimated $21.5M.
- Bridgeway Capital Management's ten largest holdings make up 6.7% of its $4.18B portfolio in Q2 2023.
- Bridgeway Capital Management opened 123 new positions and closed 123 in Q2 2023.
- Bridgeway Capital Management's portfolio value rose 11% quarter-over-quarter to $4.18B.
Based on Bridgeway Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.